<DOC>
	<DOC>NCT00299611</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness of Levetiracetam augmentation relative to Placebo in SSRI non-remitters with obsessive compulsive disorder. The hypothesis is that anxiolytic effect of Levetiracetam is more beneficial when adding with a SSRI.</brief_summary>
	<brief_title>Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder</brief_title>
	<detailed_description>This is an investigator-initiated, single-site study, consisting of two phases: 8 weeks of open-label treatment with sertraline (50mg-150mg/day) in patients iwth OCD.At week 8, those who have failed to achieve remission will be continued on sertraline and will be randomized to receive Levetiracetam (500mg-2000mg/day) or Placebo for 8 weeks.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>ages 1865 primary diagnosis of OCD based on DSMIV criteria and assessed by the MINI International Neuropsychiatric Interview YaleBrown ObsessiveCompulsive Scale (YBOCS) score of at least 16 or greater on screening Ability to provide written consent form Any primary DSMIV Axis I disorder other than OCD Substance abuse during the last 6 months A clinically unstable medical condition or clinically significant laboratory abnormalities Suicidal risk or serious suicidal attept during the last year Concurrent use of psychotropic medication including benzodiazepines, barbituates, antiepileptic drugs, antidepressants, buspirone, dietary supplements or herbal or homeopathic remedies with psychotropic effects Recent (within the last 3 months) initiation of cognitive behavioral therapy Failure of previous trial of levetiracetam at 2000 mg/day Pregnancy or lactation Women of childbearing potential who are unwilling to practice an acceptable method of contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>OCD</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Pharmacotherapy</keyword>
	<keyword>Sertraline</keyword>
	<keyword>Levetiracetam</keyword>
</DOC>